Organon & Co | Driftsresultatet

Operating Profit Endring Dato
Adcock Ingram Holdings ZAR 541.49M 52.55M 2023-06
Bristol-Myers Squibb USD 1.51B 340M 2024-03
Ecofibre AUD -3356000 20.27M 2023-06
Gilead Sciences USD -191000000 1.8B 2024-03
Kangmei Pharma CNY -21752960 44.94M 2023-09
Knight Therapeutics CAD 2.29M 1.5M 2023-09
Laboratorios Farma EUR 85.28M 66.78M 2023-06
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -11427000 4.13M 2023-06
Merck USD 5.76B 7.69B 2024-03
Neuren Pharmaceuticals AUD 48.83M 41.89M 2023-06
Organigram Holdings CAD -219637000 208.87M 2023-03
Organon & Co USD 104M 24M 2023-12
Pharma Mar EUR -4330000 788K 2024-03
Probiotec AUD 8.03M 492.24K 2023-06
Qiagen NV USD 98.24M 12.37M 2024-03
Sartorius EUR 122.3M 2.3M 2024-03
Sino Biopharmaceutical CNY 3.75B 797.83M 2023-06



Organon & Co Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.